Skip Navigation


JAC Advance Access originally published online on May 15, 2007
Journal of Antimicrobial Chemotherapy 2007 60(1):166-169; doi:10.1093/jac/dkm128
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/1/166    most recent
dkm128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dalley, A. J.
Right arrow Articles by Cross, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalley, A. J.
Right arrow Articles by Cross, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Inadequate antimicrobial prophylaxis during surgery: a study of ß-lactam levels during burn debridement

Andrew J. Dalley1,2, Jeffrey Lipman1,3, Bala Venkatesh4, Michael Rudd5, Michael S. Roberts2 and Sheree E. Cross2,*

1 Burns Trauma and Critical Care Research Centre, University of Queensland, Brisbane, Queensland, Australia 2 Therapeutics Research Unit, School of Medicine, University of Queensland, Brisbane, Queensland, Australia 3 Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia 4 Department of Intensive Care Medicine, Princess Alexandra and Wesley Hospitals, Brisbane, Queensland, Australia 5 Department of Surgery, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia

Received 13 February 2007; returned 11 March 2007; revised 28 March 2007; accepted 5 April 2007


* Correspondence address. Therapeutics Research Unit, School of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Queensland 4102, Australia. Tel: +61-7-3240-5364; Fax: +61-7-3240-5806; E-mail: s.cross{at}uq.edu.au

Objectives: To determine how long single-dose prophylactic antibiotic regimens for burns surgery maintained plasma concentrations above the MICs for target organisms during surgery.

Patients and methods: We monitored antibiotic plasma concentrations in 12 patients (mean ± SD 43 ± 12% total burn surface area) throughout debridement surgery after administration of the standard prophylactic antibiotic dosing regimens of either 1 g of intravenous cefalotin or 4.5 g of intravenous piperacillin/tazobactam.

Results: The eschar debridement and grafting procedures ranged in duration from 2.25 to over 8.5 h. The duration of total plasma cefalotin concentration above an MIC of 0.2 mg/L for Staphylococcus aureus was 6.49 ± 2.85 h, whereas the mean duration of total plasma piperacillin concentration above an MIC of 64 mg/L for Pseudomonas aeruginosa was only 1.15 ± 0.59 h. None of the patients dosed with piperacillin/tazobactam was adequately protected for the duration of their surgery and adequate prophylaxis was only evident in four of the nine patients administered cefalotin.

Conclusions: These results suggest a need to review antibiotic prophylaxis dosage regimens for burns surgery and the adoption of regimens that will minimize the risk of infection in this high-risk patient group. It is suggested that the antibiotic prophylaxis guideline for burn debridement surgery be modified to include re-dosing or a continuous infusion of ß-lactam antibiotics.

Keywords: antibiotic prophylaxis , intraoperative period , drug administration schedule , adult burns


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. J. Dalley, R. Deans, J. Lipman, B. Venkatesh, M. Rudd, M. S. Roberts, and S. E. Cross
Unbound Cephalothin Pharmacokinetics in Adult Burn Patients Are Related to the Elapsed Time after Injury
Antimicrob. Agents Chemother., December 1, 2009; 53(12): 5303 - 5305.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. J. Dalley, J. Lipman, R. Deans, B. Venkatesh, M. Rudd, M. S. Roberts, and S. E. Cross
Tissue Accumulation of Cephalothin in Burns: a Comparative Study by Microdialysis of Subcutaneous Interstitial Fluid Cephalothin Concentrations in Burn Patients and Healthy Volunteers
Antimicrob. Agents Chemother., January 1, 2009; 53(1): 210 - 215.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Bohannon, W. Cui, R. Cox, R. Przkora, E. Sherwood, and T. Toliver-Kinsky
Prophylactic Treatment with Fms-Like Tyrosine Kinase-3 Ligand after Burn Injury Enhances Global Immune Responses to Infection
J. Immunol., March 1, 2008; 180(5): 3038 - 3048.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.